Johnson & Johnson raises guidance for 2026 on strong start to the year

By:
On:
URL has been copied successfully!
Johnson & Johnson said its pharmaceutical sales rose 11.2% in the first quarter of 2026.
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here.